Page last updated: 2024-10-22

ambroxol and Colitis Gravis

ambroxol has been researched along with Colitis Gravis in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cavalu, S1
Sharaf, H1
Saber, S1
Youssef, ME1
Abdelhamid, AM1
Mourad, AAE1
Ibrahim, S1
Allam, S1
Elgharabawy, RM1
El-Ahwany, E1
Amin, NA1
Shata, A1
Eldegla, M1
Atef, M1
Aboraya, M1
Mohamed, M1
Anz, N1
Elmotelb, DA1
Gabr, F1
Elzablawy, D1
Hamada, M1
Yehia, A1
Osama, D1
Mohammed, OA1

Other Studies

1 other study available for ambroxol and Colitis Gravis

ArticleYear
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:9

    Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Colitis, Ulcerative; Colon; Ex

2022